Third-year Elon Law student Bernard Brown was a panelist at the North Carolina Central University School of Law Biotechnology and Pharmaceutical Law Review symposium on March 19, representing the law firm of Womble Carlyle Sandridge and Rice PLLC, where Brown serves as a patent agent.
At the symposium, Brown discussed the potential impact on DNA patents of the pending Association for Molecular Pathology, et al. v. United States Patent and Trademark Office, et al. case.
In addition, Brown recently co-authored an article on the impacts of patenting and the patent review process on the emerging field of nanotechnology, with Womble Carlyle attorneys Greg Grissett and Jack Hicks. Hicks also serves as an adjunct professor and preceptor at Elon Law.
The article, “Patenting Nanotechnology: Is There Really Plenty of Room at the Bottom?,” appeared in the March 2010 edition of IP Links, published by the North Carolina Bar Association’s Intellectual Property Section.
Brown, Grissett and Hicks also co-authored the article, “Nanoscience Patents Needs Assessment: Where Are We And Where Do We Go From Here?,” presented by Hicks at the Society for the Study of Nanoscience and Emerging Technologies Conference in Seattle this past September. Click here for a report on that paper, including comments from Brown.
Before coming to Elon Law, Brown obtained a Ph.D. in biochemistry from North Carolina State University. He also holds degrees in chemistry and zoology and served as an assistant professor in the Department of Chemistry at Wake Forest University.
The Biotechnology and Pharmaceutical Law Review symposium was held at the North Carolina Biotechnology Center in Research Triangle Park, North Carolina. In its fourth year, the symposium is designed to address both policy considerations and business perspectives within biotechnology and pharmaceutical arenas.
Click on the E-Cast link to the right of this article to read Brown’s most recent co-authored article on patenting nanotechnology.
By Danielle Appelman, L’12